Article Versions Notes

Elsesy ME, Oh-Hohenhorst SJ, Löser A, Oing C, Mutiara S, Köcher S, Meien S, Zielinski A, Burdak-Rothkamm S, Tilki D, et al. Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair. Cancers. 2020; 12(9):2467. https://doi.org/10.3390/cancers12092467

Elsesy, Mohamed E., Su Jung Oh-Hohenhorst, Anastassia Löser, Christoph Oing, Sally Mutiara, Sabrina Köcher, Stefanie Meien, Alexandra Zielinski, Susanne Burdak-Rothkamm, Derya Tilki, and et al. 2020. "Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair" Cancers 12, no. 9: 2467. https://doi.org/10.3390/cancers12092467

Elsesy, M. E., Oh-Hohenhorst, S. J., Löser, A., Oing, C., Mutiara, S., Köcher, S., Meien, S., Zielinski, A., Burdak-Rothkamm, S., Tilki, D., Huland, H., Schwarz, R., Petersen, C., Bokemeyer, C., Rothkamm, K., & Mansour, W. Y. (2020). Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair. Cancers, 12(9), 2467. https://doi.org/10.3390/cancers12092467